FOMX - Foamix Pharmaceuticals Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5183.21M
Enterprise Value 384.63M
Trailing P/E N/A
Forward P/E 1-2.44
PEG Ratio (5 yr expected) 10.02
Price/Sales (ttm)50.96
Price/Book (mrq)1.99
Enterprise Value/Revenue 323.54
Enterprise Value/EBITDA 6-1.13

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,083.23%

Management Effectiveness

Return on Assets (ttm)-50.88%
Return on Equity (ttm)-92.25%

Income Statement

Revenue (ttm)3.6M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-17.50%
Gross Profit (ttm)3.6M
EBITDA -74.57M
Net Income Avi to Common (ttm)-74.16M
Diluted EPS (ttm)-1.6990
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.58M
Total Cash Per Share (mrq)1.81
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.66
Book Value Per Share (mrq)1.70

Cash Flow Statement

Operating Cash Flow (ttm)-68.66M
Levered Free Cash Flow (ttm)-41.77M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.28
52-Week Change 3-32.81%
S&P500 52-Week Change 38.62%
52 Week High 37.6000
52 Week Low 33.2100
50-Day Moving Average 33.8524
200-Day Moving Average 33.9893

Share Statistics

Avg Vol (3 month) 3378.17k
Avg Vol (10 day) 3351.04k
Shares Outstanding 554.37M
Float 34.63M
% Held by Insiders 10.70%
% Held by Institutions 1291.23%
Shares Short (Mar 29, 2019) 41.67M
Short Ratio (Mar 29, 2019) 43.37
Short % of Float (Mar 29, 2019) 43.08%
Short % of Shares Outstanding (Mar 29, 2019) 43.07%
Shares Short (prior month Feb 28, 2019) 42.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A